Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
about
Platelets, petechiae, and preservation of the vascular wallA combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivoMulti-gene targeted antiangiogenic therapies for experimental corneal neovascularization.Significance of lipid mediators in corneal injury and repair.Corneal neovascularization: an anti-VEGF therapy review.A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.Limbal stem cell deficiency and corneal neovascularization.Novel aspects of corneal angiogenic and lymphangiogenic privilege.Ocular actions of platelet-activating factor: clinical implications.Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species.Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line.Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokinesNuclear localization of platelet-activating factor receptor controls retinal neovascularization.Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells.Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor.Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.Age-Related Macular Degeneration: Pathogenesis, Genetic Background, and the Role of Nutritional Supplements
P2860
Q33381203-77F1299B-0DD8-403D-B209-49136F7BA514Q33576606-8E106FFF-20EB-422D-82E5-75CC882719BAQ33694084-D287931A-316A-4F1A-BA1D-8154901527C5Q33784586-914993CF-FD40-4E68-AC6D-C9463505AEDBQ34641522-427C4377-8C77-4294-B443-3C85D08C402FQ34797862-95F2774E-AC46-4ABC-93E2-680816330D58Q35145112-FBCA2818-DC33-43A5-B2F7-B8875AB71C07Q37479357-16909FCD-61DA-439B-8A38-32A275CB58A7Q37681157-99517CD3-E740-431E-8F02-F5873E80487AQ38038206-96B4D84B-FB4D-4BDC-A0FC-6048EEF8DCEDQ39357300-1ABACA8C-6CB9-467D-83B0-765E699BE69DQ40270351-417951A0-D990-4B34-AC8B-2441E96BA99CQ41852217-D5EE01E6-DB05-4660-963C-7F2029B46943Q42425245-62CAE980-41B5-47BE-BF02-5B650A7FE052Q43230859-C695EF90-3E11-4627-80B9-9E5AC9182991Q46863316-CF86AC9A-A404-4240-8DFE-4A5AB07A2766Q53285395-79D3AAFF-63ED-4344-A056-84F87B5B5286Q59055823-ACF4D4B4-D8AE-43AF-8C40-CC00D4DD4232
P2860
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Platelet-activating factor (PA ...... pression in endothelial cells.
@ast
Platelet-activating factor (PA ...... pression in endothelial cells.
@en
type
label
Platelet-activating factor (PA ...... pression in endothelial cells.
@ast
Platelet-activating factor (PA ...... pression in endothelial cells.
@en
prefLabel
Platelet-activating factor (PA ...... pression in endothelial cells.
@ast
Platelet-activating factor (PA ...... pression in endothelial cells.
@en
P2093
P356
P1476
Platelet-activating factor (PA ...... pression in endothelial cells.
@en
P2093
Haydee E P Bazan
Nicolas G Bazan
Paulo Ottino
P304
P356
10.1167/IOVS.04-0128
P407
P577
2004-09-01T00:00:00Z